SARS CoV 2 News and Research

RSS

Facemasks significantly reduce simulated SARS-CoV-2 transmission in classroom setting

Researchers at the University of Wisconsin-Madison have conducted a study showing that wearing facemasks in the classroom setting can be highly effective at reducing the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

7 Jan 2021

How has the COVID-19 pandemic affected the mental health of older adults? A UK case study

A team of researchers at University College London, UK, recently explored how the COVID-19 pandemic has affected the mental health of older adults across Britain.

7 Jan 2021

SARS-CoV-2 viral load in saliva may be linked to COVID-19 disease severity

Researchers at Yale University School of Medicine found that SARS-CoV-2 viral loads in saliva are higher for patients with associated risk factors and underlying conditions that lead to severe COVID-19 and death. Thus, saliva viral loads could be used to predict disease severity.

7 Jan 2021

Males at higher risk of severe COVID-19 and mortality in Indian case study

A new US-based study by researchers at Dartmouth College, the Development Data Lab, IDFC Institute, Johns Hopkins University, and the University of Chicago shows that the infection fatality rate (IFR) could be twice as high for men compared to women and increases much less at older ages compared to high-income countries.

7 Jan 2021

Which strain should SARS-CoV-2 vaccine candidates target?

A researcher at Clemson University, USA, has recently explored how governments might effectively combat the pandemic through strategic vaccination as new variants and strains of the virus emerge. The study suggests that vaccine candidates should target the fast-spreading variant, even when the initial prevalence is much lower.

7 Jan 2021

Covid-19 project receives government funding to expand globally

Supercomputing facilities set up to track the spread and evolution of the COVID-19 pandemic have received £1.2M in government funding to expand globally.

7 Jan 2021

Severe COVID-19 recovered patients do not display long-lasting adaptive immune responses, finds study

A team of scientists from the University of Valencia and INCLIVA Health Research Institute, Spain, has recently investigated the durability of immune responses specifically developed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).

7 Jan 2021

Researchers use nanotechnology to develop new coronavirus mask model

A US-based research team designed and fabricated electrospun nanofibrous air filters that hold promise for applications in personal protective equipment and indoor environments. The team compared the filtration efficiency of coronavirus and NaCl aerosols to a broad spectrum of electrospun air filters and face masks.

7 Jan 2021

Scientists to help nursing homes implement best practices to mitigate COVID-19 impact

Researchers in Georgia State University's School of Public Health and Emory University's School of Medicine have received a $600,000 grant from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to help nursing homes implement practices to mitigate the impact of COVID-19 and stop the spread of the SARS-CoV-2 virus.

7 Jan 2021

Danish study suggests local lockdown had no effect on SARS-CoV-2 infection rate

The onset of the coronavirus disease 2019 (COVID-19) pandemic led to severe restrictions on public mobility and interaction, national or state-wide lockdowns, school and workplace closures, and curfews. The result was widespread economic hardship, in addition to the toll on health.

7 Jan 2021

Study: Durable immunity against secondary COVID-19 disease is possible in most individuals

Researchers who studied antibody and immune cell responses in more than 180 men and women who had recovered from COVID-19 report these patients' immune memory to the virus - across all immune cell types studied - was measurable for up to 8 months after symptoms appeared.

7 Jan 2021

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is thought to have a zoonotic origin, perhaps originating in a bat coronavirus with an unknown intermediate host. It is not only very infectious but has been found to infect a wide range of mammals, including dogs, cats, ferrets, hamsters, and minks, besides non-human primates. This range may be still higher, claims a recent preprint that appeared in January 2021 on the bioRxiv server.

6 Jan 2021

Adaptive immune system against COVID-19 can last for at least eight months

New data suggest that nearly all COVID-19 survivors have the immune cells necessary to fight re-infection.

6 Jan 2021

Is one-dose COVID-19 vaccination better than two?

A recent study published on the preprint server medRxiv in December 2020 reflects on the possibility of using a single-dose vaccine regimen to accomplish large-scale vaccination as early as possible.

6 Jan 2021

Increased socializing may have jeopardized lockdown benefit in England

Researchers in the UK report that much of the potential beneficial impact of the November 2020 English National lockdown on the coronavirus disease 2019 (COVID-19) epidemic was likely undermined in many areas due to increased socializing in the days running up to its implementation.

6 Jan 2021

More stringent measures may be needed to control new SARS-CoV-2 B.1.1.7 variant in England

Researchers in the UK have conducted a comprehensive epidemiologic analysis of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in an effort to learn more about the expanded range and frequency of coronavirus disease 2019 (COVID-19) cases in England.

6 Jan 2021

In-silico modeling provides new understanding of immune response to SARS-CoV-2

The COVID-19 pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has crippled global healthcare systems and triggered an economic crisis in many countries. The pandemic is not showing signs of a slowdown even in 2021 with a new and more infectious variant of the virus wreaking havoc in the UK and many other parts of the world.

6 Jan 2021

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.

6 Jan 2021

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

In a recent bioRxiv* preprint paper, US researchers mapped in detail how mutations to the receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affected antibody binding in convalescent human serum – and revealed that it is influenced by mutations at only a handful of dominant epitopes.

6 Jan 2021

Smokers at increased risk of developing symptomatic COVID-19

Smoking is associated with an increased risk of COVID-19 symptoms and smokers are more likely to attend hospital than non-smokers, a study has found.

6 Jan 2021

SARS CoV 2 News and Research

Facemasks significantly reduce simulated SARS-CoV-2 transmission in classroom setting

How has the COVID-19 pandemic affected the mental health of older adults? A UK case study

SARS-CoV-2 viral load in saliva may be linked to COVID-19 disease severity

Males at higher risk of severe COVID-19 and mortality in Indian case study

Which strain should SARS-CoV-2 vaccine candidates target?

Covid-19 project receives government funding to expand globally

Severe COVID-19 recovered patients do not display long-lasting adaptive immune responses, finds study

Researchers use nanotechnology to develop new coronavirus mask model

Scientists to help nursing homes implement best practices to mitigate COVID-19 impact

Danish study suggests local lockdown had no effect on SARS-CoV-2 infection rate

Study: Durable immunity against secondary COVID-19 disease is possible in most individuals

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

Adaptive immune system against COVID-19 can last for at least eight months

Is one-dose COVID-19 vaccination better than two?

Increased socializing may have jeopardized lockdown benefit in England

More stringent measures may be needed to control new SARS-CoV-2 B.1.1.7 variant in England

In-silico modeling provides new understanding of immune response to SARS-CoV-2

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

Smokers at increased risk of developing symptomatic COVID-19

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News